The fact
New therapeutic option for patients with this tumor type.
Click the link to read an article on the topic:
Observed impact
EMA approuve abémaciclib cancer du sein hormonosensible
Story timeline
Apr 30EMA confirms abemaciclib benefit in hormone-sensitive breast cancerthis article